The trial is conducted at the Mays Cancer Center, part of the University of Texas at San Antonio’s Health Science Center.

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient has been dosed in the ...

SOUTH SAN FRANCISCO, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the"Company") (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline ...

First-in-human study evaluates safety, pharmacokinetics, biomarker analyses, target engagement, and anti-tumor activity in patients with advanced solid tumors ST-01156 has received U.S. FDA Orphan ...

A Registrational Phase 2 clinical trial has been initiated in Japan for patients with PSMA-positive metastatic castration-resistant prostate cancer (mCRPC). BOSTON, Feb. 04, 2026 (GLOBE NEWSWIRE) -- ...

Neomorph, Inc., a biotechnology company pioneering molecular glue degraders to address previously undruggable proteins, today announced the first patient has been dosed in the Phase 1/2 clinical trial ...

Roger Jackson, 80, from Bedford, had the incisionless treatment for liver cancer and was discharged the next day [Cambridge University Hospitals NHS Foundation Trust] A hospital has become the first ...

In a recent study, researchers at the Texas A&M University Health Science Center (Texas A&M Health) identify a novel RNA ...

The MarketWatch News Department was not involved in the creation of this content. Elephas Live(TM) Platform to Help Increase Access to Immunotherapy for Cancer Patients in India MADISON, Wis., Oct. 9, ...

Developed in Lab 22 at Australia’s CSIRO and designed by a Melbourne-based medical device company called Anatomics, a 3D-printed titanium sternum and rib cage have been planted into a 54-year old ...